Insider Shareholders with Direct Ownership of Optimize Rx Corp (OPRX)
This section provides a comprehensive overview of the insiders with direct ownership of Optimize Rx Corp (OPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
OptimizeRx Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
William J Febbo
CEO |
607,176 | 255,638 | 581,253 $3.03 Million | 24 |
Apr 18, 2024
Reduced 0.13%
|
|
Gus D Halas
Director |
19,029 | 0 | 80,926 $421,624 | 9 |
Jun 05, 2024
Added 11.06%
|
|
Stephen L Silvestro
Chief Commercial Officer |
224,035 | 147,253 | 76,878 $400,534 | 28 |
Oct 03, 2024
Reduced 3.29%
|
|
Miriam J Paramore
PRESIDENT AND CSO |
91,891 | 175,753 | 71,049 $370,165 | 16 |
Dec 02, 2021
Reduced 4.77%
|
|
James Paul Lang
Director |
38,315 | 0 | 68,044 $354,509 | 11 |
Jun 07, 2024
Added 16.34%
|
|
Ellen O'Connor Vos
Director |
32,815 | 0 | 62,774 $327,052 | 11 |
Jun 07, 2024
Added 17.47%
|
|
Gregory D Wasson
Director |
32,315 | 0 | 47,315 $246,511 | 10 |
Jun 07, 2024
Added 21.92%
|
|
Patrick D Spangler
Director |
32,315 | 6,252 | 45,467 $236,883 | 11 |
Jun 07, 2024
Added 22.61%
|
|
Theresa Greco
Chief Commercial Officer |
18,519 | 0 | 37,038 $192,967 | 1 |
Nov 01, 2023
Added 33.33%
|
|
Douglas P Baker
CHIEF FINANCIAL OFFICER |
105,316 | 161,222 | 34,796 $181,287 | 35 |
Oct 05, 2021
Reduced 22.32%
|
|
Edward Stelmakh
CFO/COO |
74,186 | 18,965 | 33,366 $173,836 | 12 |
Oct 11, 2024
Reduced 5.83%
|
|
Marion Odence Ford
General Counsel and CCO |
35,677 | 12,482 | 23,195 $120,845 | 20 |
Oct 03, 2024
Reduced 7.76%
|
|
Doug Besch
Chief Product Officer |
10,648 | 1,952 | 10,196 $53,121 | 5 |
Oct 03, 2024
Reduced 8.74%
|
|
Cathy Klema
Director |
6,643 | 0 | 6,643 $34,610 | 1 |
Jun 07, 2024
Added 50.0%
|
|
Todd Inman
Chief Technology Officer |
771 | 233 | 538 $2,802 | 2 |
Mar 01, 2023
Reduced 30.22%
|